Skip to content

Public FDA record

Z-1310-2021: Drill Bit, Cannulated, 5.0 mm - Product Usage: may be used in a variety of foot and ankle procedures.

Recall record Z-1310-2021 for Arthrex, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1310-2021
Company in FDA record
Arthrex, Inc.
FDA record creation date
Mar 26, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The color indicator on the proximal end of the shaft of the AR-8770-02 is the incorrect color.

Source facts

Action
Consignees were notified via e-mail with URGENT: RECALL NOTIFICATION dated 02/23/2021. The letter identified affected product, reason for recall, and instructed consignee to immediately discontinue use, sale, and distribution of the product as well instructions for handling of affected product.
Initiated
2021-02-24
Root cause
Under Investigation by firm
Terminated
2023-05-02
Distribution
US Nationwide distribution in the states of Ohio, Oregon, Tennessee, Texas.
Recall number
Z-1310-2021
Recall status
Terminated
CDRH record ID
186138
FDA record created
2021-03-26
Recall event number
87481

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗